Soichiro Yamamura

Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha.

E protein silencing by the leukemogenic AML1-ETO fusion protein.

Structural and functional organization of TRAP220, the TRAP/mediator subunit that is targeted by nuclear receptors.

Sphingosine 1-phosphate breakdown in platelets.

MED1/TRAP220 exists predominantly in a TRAP/ Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription.

Wnt antagonist gene polymorphisms and renal cancer.

Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.

Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways.

Restoring erectile function by antioxidant therapy in diabetic rats.

Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.

Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.

Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer.

Oncogenic functions of secreted Frizzled-related protein 2 in human renal cancer.

Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.

MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer.

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.

MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.

MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.

Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer.

MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells.

Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.

MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.

Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway.

MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells.

Up-regulation of microRNA-21 correlates with lower kidney cancer survival.

miRNA-708 control of CD44(+) prostate cancer-initiating cells.

Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151.

MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer.

miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.

miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.

Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.

Hrk mediates 2-methoxyestradiol-induced mitochondrial apoptotic signaling in prostate cancer cells.

MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.

Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR.

MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases.

Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells.

Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer.

Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.

DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.

Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.

Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma.

Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells.

CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma.

Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer.